DE69620573T2 - Mittel zur verminderung des augeninnendrucks - Google Patents

Mittel zur verminderung des augeninnendrucks

Info

Publication number
DE69620573T2
DE69620573T2 DE69620573T DE69620573T DE69620573T2 DE 69620573 T2 DE69620573 T2 DE 69620573T2 DE 69620573 T DE69620573 T DE 69620573T DE 69620573 T DE69620573 T DE 69620573T DE 69620573 T2 DE69620573 T2 DE 69620573T2
Authority
DE
Germany
Prior art keywords
agent
pressure reduction
ocular tension
ocular
decreasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69620573T
Other languages
English (en)
Other versions
DE69620573D1 (de
Inventor
Hajimu Kurumatani
Ayako Kawashima
Masafumi Isogaya
Hisanori Wakita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of DE69620573D1 publication Critical patent/DE69620573D1/de
Application granted granted Critical
Publication of DE69620573T2 publication Critical patent/DE69620573T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Window Of Vehicle (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Laser Surgery Devices (AREA)
DE69620573T 1995-11-14 1996-11-14 Mittel zur verminderung des augeninnendrucks Expired - Fee Related DE69620573T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29578995 1995-11-14
PCT/JP1996/003351 WO1997017974A1 (fr) 1995-11-14 1996-11-14 Depresseur oculaire

Publications (2)

Publication Number Publication Date
DE69620573D1 DE69620573D1 (de) 2002-05-16
DE69620573T2 true DE69620573T2 (de) 2002-08-08

Family

ID=17825188

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69620573T Expired - Fee Related DE69620573T2 (de) 1995-11-14 1996-11-14 Mittel zur verminderung des augeninnendrucks

Country Status (11)

Country Link
US (1) US6127413A (de)
EP (1) EP0795331B1 (de)
KR (1) KR19980701417A (de)
CN (1) CN1127342C (de)
AT (1) ATE215824T1 (de)
AU (1) AU717104B2 (de)
CA (1) CA2210255A1 (de)
DE (1) DE69620573T2 (de)
ES (1) ES2171742T3 (de)
NO (1) NO973122L (de)
WO (1) WO1997017974A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1126545C (zh) * 1996-05-07 2003-11-05 东丽株式会社 眼科用制剂
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
US20090016981A1 (en) 2006-05-03 2009-01-15 Allergan, Inc. Therapeutic compounds
PT2343292E (pt) 2008-09-10 2014-11-04 Kaken Pharma Co Ltd Novo derivado de prostaglandina i2
BR112012022632B1 (pt) * 2010-03-08 2020-03-31 Kaken Pharmaceutical Co., Ltd. Medicamento compreendendo Agonista de ep4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476684A1 (fr) * 1980-02-21 1981-08-28 Interox Procede pour inhiber la corrosion d'appareils en titane
CA1275287C (en) * 1986-01-24 1990-10-16 Kiyotaka Ohno 2,5,6,7-tetranor-4,8-inter-m-phanylene pgi derivatives
DE3886936T2 (de) * 1987-10-16 1994-04-28 Toray Industries 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
CN1126545C (zh) * 1996-05-07 2003-11-05 东丽株式会社 眼科用制剂

Also Published As

Publication number Publication date
CN1127342C (zh) 2003-11-12
CA2210255A1 (en) 1997-05-22
NO973122L (no) 1997-08-27
WO1997017974A1 (fr) 1997-05-22
EP0795331A1 (de) 1997-09-17
EP0795331A4 (de) 1999-07-14
AU7587396A (en) 1997-06-05
DE69620573D1 (de) 2002-05-16
ATE215824T1 (de) 2002-04-15
CN1177926A (zh) 1998-04-01
KR19980701417A (ko) 1998-05-15
ES2171742T3 (es) 2002-09-16
EP0795331B1 (de) 2002-04-10
US6127413A (en) 2000-10-03
AU717104B2 (en) 2000-03-16
NO973122D0 (no) 1997-07-04

Similar Documents

Publication Publication Date Title
HU9600834D0 (en) Quinazoline derivatives
LU90969I2 (fr) Compositions ophtalmiques topiques contenant olopatadine destinees au tritement d'affections allergiques des yeux
DE69716226D1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
FI950309A0 (fi) Proliiniamidijohdannaisia
ATE359794T1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
AU2231797A (en) Novel iridoid derivatives and a vascularization inhibitor having for its active ingredient said derivative
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
SG42446A1 (en) Pharmaceutical composition method and device for preventing or treating dry eye or disease caused therefrom
ATE162074T1 (de) Oculare hypotensive mittel
ATE453395T1 (de) 3, 7 oder 3 und 7 thia- oder oxaprostansäure derivate als mittel zur senkung des augeninnendrucks
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
FR2754712B1 (fr) Compositions ophtalmiques
AU3453493A (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
DE69620573D1 (de) Mittel zur verminderung des augeninnendrucks
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
IL129088A0 (en) Subepithelial turbidity inhibitor
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
WO2001082913A3 (en) Use of benzamide derivatives for the treatment of high ocular tension and glaucoma
TH59045B (th) อนุพันธ์อินโดลและสารผสมทางเภสัชกรรมที่ประกอบด้วยสารดังกล่าว

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee